Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of K Pharma, Inc.. A complete text table follows the diagram.
No operating revenue was reported; the company spent JPY437M on the operating base while advancing 11 drug and regenerative-medicine programs.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Operating expense base | 1 | 437M | 100.0% of reported total |
| Operating costs | 2 | 437M | JPY437M interim operating-cost base; no operating revenue reported |
| From | To | Value |
|---|---|---|
| Operating expense base | Operating costs | 437M |